RxDoctor Payments Data

Elizabeth Cruz, MD

Internal Medicine · Chicago, ILNPI 1093869141

Payments from drug & device makers

$1,813in general payments, 2019–2025

Across 86 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$452
  • Lilly USA, LLC$405
  • Novartis$305
  • Novo Nordisk$176
  • Amgen$175
  • Merck$79
  • plus $221 from 6 others

What the payments were for

  • Food & beverage$1,813100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,813 in reported general payments places this provider in the 80th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$48,784
Medicare patients
92
Services billed
418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin93$113,977
JanuviaSitagliptin Phosphate57$61,586
TradjentaLinagliptin22$28,471
TrulicityDulaglutide22$21,213
EliquisApixaban17$19,770
FarxigaDapagliflozin Propanediol15$17,992
OzempicSemaglutide18$17,370
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$8,209
JanumetSitagliptin Phos/Metformin Hcl11$7,638
Breo ElliptaFluticasone/Vilanterol16$7,505
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp29$7,043
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,756
Albuterol Sulfate HfaAlbuterol Sulfate77$3,553
Metoprolol Succinate175$3,080
Losartan Potassium156$1,888

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$452$142,448115 claims
MerckJanuvia, Janumet$79$69,22468 claims
Lilly USA, LLCTrulicity$405$21,21322 claims
PfizerEliquis$36$19,77017 claims
AstraZenecaFarxiga$63$17,99215 claims
Novo NordiskOzempic$176$17,37018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →